Results 251 to 260 of about 2,067,232 (315)

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Silanes to Silatranes: Robust Functionalization for Single-Molecule Force Spectroscopy. [PDF]

Chembiochem
Courtney TD, Hatchell CB, O X, Jacobson DR.   +3 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source

Defining peptides in ChEBI. [PDF]

J Cheminform
Flügel S, Mossakowski T, Neuhaus F, Pfanenstiel E, Glauer M, Haak E, Malik A, O'Boyle NM.   +7 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

Molecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska, Stephany Gallardo, Nur S. Zainal, Leena Arora, Matthew Ellis, Maria‐Antoinette Lopez, Judith Austine, Sai Pittla, Serena J Chee, Aiman Alzetani, Emily C Shaw, Christian H Ottensmeier, Gareth J Thomas, Christopher J Hanley   +13 more
wiley   +1 more source

Computational Insights into the Activation Mechanism of CXCR4: Implications for the Design of Small Molecule Agonists. [PDF]

J Am Chem Soc
Zhou J, Liu X, Xu Y, Cruz A, An J, Warshel A, Huang Z.   +6 more
europepmc   +1 more source

BlinkFusion: modular platform quantifying labeling efficiency and photophysics in regular and super-resolution fluorescence microscopy. [PDF]

Front Bioinform
Salgado A, Naguib N, Wiesner UB, Ávila A.   +3 more
europepmc   +1 more source

Orientational Switching as an Extra Degree of Freedom in Self-Assembled C₇₀ and Octanethiol on Au(111). [PDF]

Langmuir
Gao Y, Li B, Yang H, Ding H, Gao J, Pan M, Guo Q.   +6 more
europepmc   +1 more source